673
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Perceived stigma among patients receiving antiretroviral treatment: A prospective randomised trial comparing an m-DOT strategy with standard-of- care in Kenya

Stigmatisation perçue par les patients recevant un traitement antirétroviral: un essai randomisé prospectif comparant une stratégie m-DOT (traitement modifié sous surveillance directe) à la norme de précaution au Kenya

, BEd MSc, , BSc MSc PhD, , MBBS MD MPH, , MBBCh MSc PhD DFPH, , MD MSc PhD, , MPH, , BSc, , MD, , MD PhD & show all
Pages 62-70 | Published online: 28 Feb 2012

References

  • Abusabha, R., and Woelfel, M. L., 2003. Qualitative vs quantitative methods: Two opposites that make a perfect match, Journal of the American Dietetic Association 103 (5) (2003), pp. 566–569.
  • Altice, F. L., Maru, D. S., Bruce, D. R., Springer, S. A., and Friedland, G. H., 2007. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial, Clinical Infectious Diseases 45 (6) (2007), pp. 770–778.
  • Altice, F. L., Mezger, J., Hodges, J., Bruce, R., Marinovich, A., Walton, M., et al., 2004. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication, Clinical Infectious Diseases 38 (2004), pp. S376–S387.
  • Bangsberg, D. R., Acosta, E. P., Gupta, R., Guzman, D., Riley, E. D., Harrigan, R. P., et al., 2006. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness, AIDS 20 (2) (2006), pp. 223–231.
  • Bangsberg, D. R., Ware, N., and Simoni, J. M., 2006. Adherence without access to antiretroviral therapy in sub-Saharan Africa?, AIDS 20 (1) (2006), pp. 140–141.
  • Beck, A., and Mendelson, M., 1961. Becks Depression Inventory (BDI), Archives of General Psychiatry 4 (1961), pp. 561–571.
  • Berger, B. E., Ferrans, C., and Lashley, F., 2001. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale, Research in Nursing and Health 24 (2001), pp. 518–529.
  • Carpenter, C., Cooper, D., and Fischl, M., 2000. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society - USA Panel, Journal of the American Medical Association 283 (2000), pp. 381–390.
  • Chen, S., Yu, J., Harries, A., Bong, C., Kolola-Dzimadzi, R., Tok, R., et al., 2008. Increased mortality of male adults with AIDS related to poor adherence to antiretroviral therapy in Malawi, Tropical Medicine & International Health 13 (4) (2008), pp. 513–519.
  • Christopher, G., 2006. Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions: Research directions and implications for practice, Journal of Acquired Immune Deficiency Syndromes 43 (S1) (2006), pp. S36–S40.
  • Conway, B., 2007. The role of adherence to antiretroviral therapy in the management of HIV infection, Journal of Acquired Immune Deficiency Syndromes 45 (1) (2007), pp. S14–S18.
  • Diabate, S., Alary, M., and Koffi, C., 2007. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire, AIDS 21 (13) (2007), pp. 1799–1803.
  • Dlamini, P. S., Wantland, D., Makoae, L. N., Chirwa, M., Kohi, T. W., Greeff, M., et al., 2009. HIV stigma and missed medications in HIV-positive people in five African countries, AIDS Patient Care and STDs 23 (5) (2009), pp. 377–387.
  • Farmer, P., Leandre, F., Mukherjee, J., Gupta, R., Tarter, L., and Kim, J. Y., 2001. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy), Bulletin of the World Health Organisation 79 (12) (2001), pp. 1145–1152.
  • Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., and Sabin, L. L., 2005. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa, AIDS 19 (12) (2005), pp. 1243–1249.
  • 1963. Goffman, E., ed. Stigma: Notes on the management of spoiled identity. New York: Simon & Schuster; 1963.
  • Greeff, M., and Phetlhu, R. D., 2007. The meaning and effect of HIV/AIDS stigma for people living with AIDS and nurses involved in their care in the North West Province, South Africa, Curationis 30 (2) (2007), pp. 12–23.
  • Hardon, A., Akurut, D., Comoro, C., Ekezie, C., Irunde, H., Gerrits, T., et al., 2007. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa, AIDS Care 19 (5) (2007), pp. 658–665.
  • Herek, G. M., Capitanio, J. P., and Widaman, K., 2002. HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991–1999, American Journal of Public Health 92 (2002), pp. 371–377.
  • Ickovics, J., and Meade, C., 2002. Adherence to HAART among patients with HIV: breakthroughs and barriers, AIDS Care 14 (2002), pp. 309–318.
  • Katamba, A., Neuhauser, D., Smyth, K., Adatu, F., Katabira, E., and Whalen, C., 2005. Patients perceived stigma associated with community-based directly observed therapy of tuberculosis in Uganda, East African Medical Journal 82 (7) (2005), pp. 337–342.
  • Kip, E., Ehlers, V. J., and van der Wal, D. M., 2009. Patients' adherence to anti-retroviral therapy in Botswana, Journal of Nursing Scholarship 41 (2) (2009), pp. 149–157.
  • Liechty, C. A., and Bangsberg, D. R., 2003. Doubts about DOT: antiretroviral therapy for resource-poor countries, AIDS 17 (2003), pp. 1383–1387.
  • Macalino, G., Hogan, J., Mitty, J., Bazerman, L., Delong, A., Loewenthal, H., et al., 2007. A randomised clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users, AIDS 21 (11) (2007), pp. 1473–1477.
  • Makoae, L. N., Greeff, M., Phetlhu, R. D., Uys, L. R., Naidoo, J. R., Kohi, T. W., et al., 2008. Coping with HIV-related stigma in five African countries, Journal of the Association of Nurses in AIDS Care 19 (2) (2008), pp. 137–146.
  • Malangu, N., 2008. Self-reported adverse effects as barriers to adherence to antiretroviral therapy in HIV-infected patients in Pretoria, South African Family Practice 50 (5) (2008), pp. 49–49b.
  • Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., et al., 2006. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and faciliators, Plos Medicine 3 (11) (2006), p. e438.
  • Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al., 2006. Adherence to antiretroviral therapy in sub-Saharan Africa and North America, Journal of the American Medical Association 296 (2006), pp. 679–690.
  • Mitchell, C., Freels, S., Creticos, C., Oltean, A., and Douglas, R., 2007. Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counselling, AIDS Care 19 (4) (2007), pp. 561–564.
  • Mitty, J., Stone, V., Sands, M., Macalino, G., and Flanigan, T., 2002. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress, Clinical Infectious Diseases 34 (2002), pp. 984–990.
  • Mukherjee, J., Ivers, L., Leandre, F., Farmer, P., and Behforouz, H., 2006. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence, Journal of Acquired Immune Deficiency Syndromes 43 (2006), pp. S123–S126, Suppl 1.
  • Munoz, M., Finnegan, K., Zeladita, J., Caldas, A., Sanchez, E., Callacna, M., et al., Community-based DOT-HAART accompaniment in an urban resource-poor setting, AIDS Behaviour.
  • Murray, L. K., Semrau, K., McCurley, E., Thea, D. M., Scott, N., Mwiya, M., et al., 2009. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study, AIDS Care 21 (1) (2009), pp. 78–86.
  • Nachega, J., Knowlton, A., Deluca, A., Schoeman, J. H., Watkinson, L., Efron, A., et al., 2006. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study, Journal of Acquired Immune Deficiency Syndromes 43 (2006), pp. S127–S133, Suppl 1.
  • Nyblade, L., 2006. Measuring HIV stigma: Existing knowledge and gaps, Psychology Health & Medicine 11 (3) (2006), pp. 335–345.
  • Nyblade, L., and MacQuarrie, K., 2006. Can we measure HIV/AIDS-related stigma and discrimination? Current knowledge about quantifying stigma in developing countries. Washington, DC: United States Agency for International Development; 2006.
  • Page-Shipp, L. S., Charalambous, S., Roux, S., Dias, B., Sefuti, C., Churchyard, G. J., et al., 2007. Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa, Sexually Transmitted Infections 83 (2007), pp. 383–386.
  • Pearson, C. R., Micek, M., Simoni, J. M., Hoff, P. D., Matediana, E., Martin, D. P., et al., 2007. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique, Journal of Acquired Immune Deficiency Syndromes 46 (2) (2007), pp. 238–244.
  • Pearson, C. R., Micek, M., Simoni, J. M., Matediana, E., Martin, D. P., and Gloyd, S., 2006. Modified Directly Observed Therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique: Development and implemetation, Journal of Acquired Immune Deficiency Syndromes 43 (S1) (2006), pp. S134–S141.
  • Pearson, C. R., Micek, M. A., Pfeiffer, J., Montoya, P., Matediane, E., Jonasse, T., et al., One year after ART initiation: Psychosocial factors associated with stigma among HIV positive Mozambicans, AIDS and Behavior.
  • Peltzer, K., Mosala, T., Shisana, O., Nqueko, A., and Mngqundaniso, N., 2007. Barriers to Prevention of HIV transmission from mother to child (PMTCT) in a resource poor setting in the Eastern Cape, South Africa, African Journal of Reproductive Health 11 (1) (2007), pp. 57–66.
  • PEPFAR, 2008. 2008 Country Profile: Kenya. 2008, Retrieved March 20, 2008, from http://www.pepfar.gov.
  • Plummer, M., Mshana, G., Wamoyi, J., Shigongo, Z., Hayes, R., Ross, D., et al., 2006. The man who believed he had AIDS was cured: AIDS and sexually-transmitted infection treatment-seeking behaviour in rural Mwanza, Tanzania, AIDS Care 18 (2006), pp. 4060–4066.
  • Pulerwitz, J., Michaelis, A., Lippman, S., Chinaglia, M., and Diaz, J., 2008. HIV-related stigma, service utilization, and status disclosure among truck drivers crossing the southern borders of Brazil, AIDS Care 20 (2) (2008), pp. 198–204.
  • Ramadhani, H., Thielman, N., Landman, K., Ndosi, E., Gao, F., Kirchherr, J., et al., 2007. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania, Clinical Infectious Diseases 45 (11) (2007), pp. 1492–1498.
  • Rao, D., Kekwaletswe, T., Hosek, S., Martinez, J., and Rodriguez, F., 2007. Stigma and social barriers to medication adherence with urban youth living with HIV, AIDS Care 19 (1) (2007), pp. 28–33.
  • Remien, R., Stirratt, M., Dolezal, C., Dognin, J., Wagner, G., Carballo-Diequez, A., et al., 2005. Couple-focused support to improve HIV medication adherence: a randomised controlled trial, AIDS 19 (8) (2005), pp. 807–814.
  • Roura, M., Urassa, M., Busza, J., Mbata, D., Wringe, A., and Zaba, B., 2009. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV-testing. Early evidence from rural Tanzania, Sexually Transmitted Infections 85 (4) (2009), pp. 308–312.
  • Sabin, L., DeSilva, M., Hamer, D., Xu, K., Zhang, J., Li, T., et al., Using Electronic Drug Monitor feedback to improve adherence to antiretroviral therapy among HIV positive patients in China, AIDS Behaviour.
  • Safren, S., Hendriksen, E., Desousa, N., Boswell, S., and Mayer, K., 2003. Use of an on-line pager system to increase adherence to antiretroviral medications, AIDS Care 15 (6) (2003), pp. 787–793.
  • Safren, S., Otto, M., Worth, J., Salomon, E., Johnson, W., Mayer, K., et al., 2001. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring, Behaviour Research and Therapy 39 (10) (2001), pp. 1151–1162.
  • Samet, J., Horton, N., Meli, S., Dukes, K., Tripp, T., Sullivan, L., et al., 2005. A randomised controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems, Antiviral Therapy 10 (1) (2005), pp. 83–93.
  • Sampaio-Sa, M., Page-Shafer, K., Bangsberg, D., Evans, J., Dourado, M., Teixeira, C., et al., 2008. 100% Adherence study: Educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil, AIDS Behaviour 12 (2008), pp. S54–S62, Suppl 1.
  • Santos, C. Q., Adeyemi, O., and Tenorio, A., 2006. Attitudes toward directly administered antiretroviral therapy (DAART) among HIV-positive inpatients in an inner city public hospital, AIDS Care 18 (7) (2006), pp. 808–811.
  • Sarna, A., Luchters, S., Geibel, S., Chersich, M., Munyao, P., Kaai, S., et al., 2008. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial, Journal of Acquired Immune Deficiency Syndromes 48 (5) (2008), pp. 611–619.
  • Sayles, J. N., Wong, M. D., Kinsler, J. J., Martins, D., and Cunningham, W. E., 2009. The association of stigma and self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS, Journal of General Internal Medicine 24 (10) (2009), pp. 1101–1108.
  • Simoni, J., Amico, K., Pearson, C., and Malow, R., 2008. Strategies for promoting adherence to antiretroviral therapy: A review of the literature, Current Infectious Disease Report 10 (6) (2008), pp. 515–521.
  • Smith, S., Rublein, J., Marcus, C., Brock, T., and Chesney, M., 2003. A medication self-management program to improve adherence to HIV therapy regimens, Patient Education and Counseling 50 (2) (2003), pp. 187–199.
  • Thorsen, V. C., Sundby, J., and Martinson, F., 2008. Potential initiators of HIV-related stigmatisation: Ethical and programmatic challenges of PMTCT programs. Vol. 8. Oxford: Blackwell Publishing Ltd; 2008.
  • Tuldra, A., Fumaz, C., Ferrer, M., Bayés, R., Arnó, A., Balagué, M., et al., 2000. Prospective randomised two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, Journal of Acquired Immune Deficiency Syndromes 25 (3) (2000), pp. 221–228.
  • UNAIDS, 2007. Reducing HIV stigma and discrimination: a critical part of national AIDS programmes. 2007, Retrieved 22 December, 2008, from http://data.unaids.org/pub/Report/2008/jc1420_stigma_discr_en.pdf.
  • UNAIDS & WHO, 2008. Epidemiological fact sheet on HIV and AIDS: 2008 update, Kenya. Geneva: UNAIDS and WHO; 2008.
  • Wakabi, W., 2008. Low ART adherence in Africa, The Lancet Infectious Diseases 8 (2) (2008), p. 94.
  • Weber, R., Christen, L., Christen, S., Tschopp, S., Znoj, H., Schneider, C., et al., 2004. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial, Antiviral Therapy 9 (1) (2004), pp. 85–95.
  • Weidle, P., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W., et al., 2006. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda, Lancet 368 (9547) (2006), pp. 1587–1594.
  • Wolfe, W., Weiser, S., Bangsberg, D., Thior, I., Makhema, J., Dickinson, D., et al., 2006. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana, AIDS Care 18 (8) (2006), pp. 931–933.
  • Wong, I., Lawrence, N., Struthers, H., McIntyre, J., and Friedland, G., 2006. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa, Journal of Acquired Immune Deficiency Syndromes 43 (2006), pp. S142–S148, Suppl 1.